Parvus and Genentech to develop treatment options in gastroenterology

The companies intend to develop therapeutics for inflammatory bowel disease, autoimmune liver diseases and celiac disease. Credit: Marco Verch/Flickr.



  • Parvus Therapeutics and Genentech partner to develop new therapies